German Inquiry Finds Flaws, Not Fraud

+ See all authors and affiliations

Science  22 Nov 2002:
Vol. 298, Issue 5598, pp. 1531-1533
DOI: 10.1126/science.298.5598.1531b

You are currently viewing the summary.

View Full Text


BERLIN-- A paper claiming a spectacular remission of tumors from the use of an experimental cancer vaccine is marred by shoddy scientific practices, but investigators aren't saying whether the results are also too good to be true. Last week the University of Göttingen said that its investigative committee had found evidence of sloppiness that constitutes misconduct, but not fraud, in the disputed paper. But with only a brief statement to go on, scientists following up on the work still don't know whether the data are valid.

Related Content